Encapsulation of antioxidants in gastrointestinal-resistant nanoparticulate carriers

Methods in Molecular Biology

Volumn 1028, Issue , 2013, Pages 37-46

  Souto, Eliana B ^a   Severino, Patrícia ^a,b   Basso, Rafael ^b   Santana, Maria Helena A ^b  

^a UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Antioxidants; Bioavailability; Disease; Nanoparticles; Oral administration

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CURCUMIN; LIPOSOME; LYCOPENE; NANOPARTICLE; POLYMERIC NANOPARTICLE; POLYPHENOL; QUERCETIN; RESVERATROL; RETINOL; SILYMARIN; SOLID LIPID NANOPARTICLE; SUPEROXIDE DISMUTASE; UBIDECARENONE; UNCLASSIFIED DRUG;

DRUG DELIVERY SYSTEM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 84882799909     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-475-3_3     Document Type: Review

References (71)

1. Huang X, Liu Y, Liang K, Tang Y, Liu J (2008) Construction of the active site of glutathione peroxidase on polymer-based nanoparticles. Biomacromolecules 9:1467-1473
2. Naik E, Dixit VM (2011) Mitochondrial reactive oxygen species drive proinfl ammatory cytokine production. J Exp Med 208:417-420
3. Nur E, Biemond BJ, Otten HM, Brandjes DP, Schnog JJ (2011) Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. Am J Hematol 86:484-489
4. Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78: 547-581
5. Halliwell B, Gutteridge JM (1984) Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1:1396-1397
6. Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK, Kumar MN (2006) Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J Control Release 113:189-207
7. Park JG, Yoo JY, Jeong SJ, Choi JH, Lee MR, Lee MN, Lee JH, Kim HC, Jo H, Yu DY, Kang SW, Rhee SG, Lee MH, Oh GT (2011) Peroxiredoxin 2 defi ciency exacerbates atherosclerosis in apolipoprotein E-defi cient mice. Circ Res 109(7):739-749
8. Houston MC (2011) Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. J Clin Hypertens (Greenwich) 13:621-627
9. Drummond GR, Selemidis S, Griendling KK, Sobey CG (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10: 453-471
10. Yang H, Jin X, Wai Kei Lam C, Yan SK (2011) Review: Oxidative stress and diabetes mellitus. Clin Chem Lab Med 49(11):1773-1782
11. Farboud ES, Nasrollahi SA, Tabbakhi Z (2011) Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: In vitro and in vivo studies. Int J Nanomedicine 6: 611-617
12. Riemann A, Schneider B, Ihling A, Nowak M, Sauvant C, Thews O, Gekle M (2011) Acidic environment leads to ROS-induced MAPK signaling in cancer cells. PLoS One 6:e22445
13. Klyachko NL, Manickam DS, Brynskikh AM, Uglanova SV, Li S, Higginbotham SM, Bronich TK, Batrakova EV, Kabanov AV (2012) Crosslinked antioxidant nanozymes for improved delivery to CNS. Nanomedicine 8:119-129
14. Tasset I, Pontes AJ, Hinojosa AJ, de la Torre R, Tunez I (2011) Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced Huntington's disease-like rat model. Nutr Neurosci 14:106-111
15. Caccamo D, Curro M, Ferlazzo N, Condello S, Ientile R (2012) Monitoring of transglutaminase2 under different oxidative stress conditions. Amino Acids 42:1037-1043
16. Lee DM, Jackson KW, Knowlton N, Wages J, Alaupovic P, Samuelsson O, Saeed A, Centola M, Attman PO (2011) Oxidative stress and infl ammation in renal patients and healthy subjects. PLoS One 6:e22360
17. Gao Z, Spilk S, Momen A, Muller MD, Leuenberger UA, Sinoway LI (2012) Vitamin C prevents hyperoxia-mediated coronary vasoconstriction and impairment of myocardial function in healthy subjects. Eur J Appl Physiol 112:483-492
18. Tian YY, Ge L, Duan XL, Gao ZQ, Chang YZ (2007) Lycopene liposomes: Lycopene release in vitro and pharmaceutical behaviors and antioxidation in vivo. Yao Xue Xue Bao 42: 1107-1111
19. Huang MH, Wang BS, Chiu CS, Amagaya S, Hsieh WT, Huang SS, Shie PH, Huang GJ (2011) Antioxidant, antinociceptive, and antiinfl ammatory activities of Xanthii Fructus extract. J Ethnopharmacol 135:545-552
20. Dube A, Nicolazzo JA, Larson I (2010) Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate. Eur J Pharm Sci 41:219-225
21. Ratnam DV, Chandraiah G, Meena AK, Ramarao P, Kumar MN (2009) The coencapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorates hyperlipidemia in high fat diet fed rats. J Nanosci Nanotechnol 9:6741-6746
22. Li H, Zhao X, Ma Y, Zhai G, Li L, Lou H (2009) Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 133:238-244
23. Setthacheewakul S, Kedjinda W, Maneenuan D, Wiwattanapatapee R (2010) Controlled release of oral tetrahydrocurcumin from a novel self-emulsifying fl oating drug delivery system (SEFDDS). AAPS PharmSciTech 12:152-164
24. Amin KA, Hassan MS, Awadel ST, Hashem KS (2011) The protective effects of cerium oxide nanoparticles against hepatic oxidative damage induced by monocrotaline. Int J Nanomedicine 6:143-149
25. Bimbo LM, Makila E, Laaksonen T, Lehto VP, Salonen J, Hirvonen J, Santos HA (2011) Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. Biomaterials 32:2625-2633
26. Gabor F, Fillafer C, Neutsch L, Ratzinger G, Wirth M (2008) Improving oral delivery. Handb Exp Pharmacol 197:345-398
27. Wilfart A, Montagne L, Simmins H, Noblet J, Milgen J (2007) Digesta transit in different segments of the gastrointestinal tract of pigs as affected by insoluble fi bre supplied by wheat bran. Br J Nutr 98:54-62
28. Thubagere A, Reinhard BM (2010) Nanoparticle-induced apoptosis propagates through hydrogen-peroxide-mediated bystander killing: Insights from a human intestinal epithelium in vitro model. ACS Nano 4: 3611-3622
29. Kesisoglou F, Panmai S, Wu Y (2007) Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 59:631-644
30. Ramesan RM, Sharma CP (2009) Challenges and advances in nanoparticle-based oral insulin delivery. Expert Rev Med Devices 6:665-676
31. Azzi A, Davies KJ, Kelly F (2004) Free radical biology-Terminology and critical thinking. FEBS Lett 558:3-6
32. Yin Y, Huang X, Lv C, Wang L, Yu S, Luo Q, Xu J, Liu J (2010) Construction of an artifi cial glutathione peroxidase active site on copolymer vesicles. Macromol Biosci 10:1505-1516
33. McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055
34. Miriyala S, Holley AK, St Clair DK (2011) Mitochondrial superoxide dismutase-signals of distinction. Anticancer Agents Med Chem 11:181-190
35. Iborra M, Moret I, Rausell F, Bastida G, Aguas M, Cerrillo E, Nos P, Beltran B (2011) Role of oxidative stress and antioxidant enzymes in Crohn's disease. Biochem Soc Trans 39:1102-1106
36. Bertini I, Mangani S, Viezzoli MS (1998) Structure and properties of copper-zinc superoxide dismutases. Adv Inorg Chem 45(45): 127-250
37. Chong-Han K (2011) Dietary lipophilic antioxidants: Implications and signifi cance in the aging process. Crit Rev Food Sci Nutr 50: 931-937
38. Aberg F, Appelkvist EL, Dallner G, Ernster L (1992) Distribution and redox state of ubiquinones in rat and human tissues. Arch Biochem Biophys 295:230-234
39. Wang Y, Xu H, Fu Q, Ma R, Xiang J (2011) Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in Parkinsonian rats. J Neurol Sci 304:29-34
40. Saito ST, Gosmann G, Pungartnik C, Brendel M (2009) Green tea extract-patents and diversity of uses. Recent Pat Food Nutr Agric 1:203-215
41. Firuzi O, Miri R, Tavakkoli M, Saso L (2011) Antioxidant therapy: Current status and future prospects. Curr Med Chem 18:3871-3888
42. Van der Loo B, Bachschmid M, Spitzer V, Brey L, Ullrich V, Luscher TF (2003) Decreased plasma and tissue levels of vitamin C in a rat model of aging: Implications for antioxidative defense. Biochem Biophys Res Commun 303:483-487
43. Taha E, Ghorab D, Zaghloul AA (2007) Bioavailability assessment of vitamin A selfnanoemulsifi ed drug delivery systems in rats: A comparative study. Med Princ Pract 16: 355-359
44. D'Ambrosio DN, Clugston RD, Blaner WS (2011) Vitamin A metabolism: An update. Nutrients 3:63-103
45. Orsucci D, Mancuso M, Ienco EC, Logerfo A, Siciliano G (2011) Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. Curr Med Chem 18(26):4053-4064
46. Kalayci M, Unal MM, Gul S, Acikgoz S, Kandemir N, Hanci V, Edebali N, Acikgoz B (2011) The effect of coenzyme Q10 on ischemia and neuronal damage in an experimental traumatic brain injury model in rats. BMC Neurosci 12:75
47. Villalba JM, Parrado C, Santos-Gonzalez M, Alcain FJ (2010) Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. Expert Opin Investig Drugs 19:535-554
48. Seo DW, Kang MJ, Sohn Y, Lee J (2009) Selfmicroemulsifying formulation-based oral solution of coenzyme Q10. Yakugaku Zasshi 129:1559-1563
49. Lopes CM, Martins-Lopes P, Souto EB (2010) Nanoparticulate carriers (NPC) for oral pharmaceutics and nutraceutics. Pharmazie 65:75-82
50. Harde H, Das M, Jain S (2011) Solid lipid nanoparticles: An oral bioavailability enhancer vehicle. Expert Opin Drug Deliv 8(11):1407-1424
51. Bansal SS, Goel M, Aqil F, Vadhanam MV, Gupta RC (2011) Advanced drug delivery systems of curcumin for cancer chemoprevention. Cancer Prev Res (Phila) 4:1158-1171
52. Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA (2008) Emerging nanopharmaceuticals. Nanomedicine 4:273-282
53. Barea MJ, Jenkins MJ, Gaber MH, Bridson RH (2010) Evaluation of liposomes coated with a pH responsive polymer. Int J Pharm 402:89-94
54. Ghosh A, Mandal AK, Sarkar S, Das N (2011) Hepatoprotective and neuroprotective activity of liposomal quercetin in combating chronic arsenic induced oxidative damage in liver and brain of rats. Drug Deliv 18:451-459
55. Takahashi M, Uechi S, Takara K, Asikin Y, Wada K (2009) Evaluation of an oral carrier system in rats: Bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem 57:9141-9146
56. Wagoner J, Morishima C, Graf TN, Oberlies NH, Teissier E, Pecheur EI, Tavis JE, Polyak SJ (2011) Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and infl ammation. PLoS One 6:e16464
57. Yan-yu X, Yun-mei S, Zhi-peng C, Qi-neng P (2006) Preparation of silymarin proliposome: A new way to increase oral bioavailability of silymarin in beagle dogs. Int J Pharm 319:162-168
58. Nacka F, Cansell M, Meleard P, Combe N (2001) Incorporation of alpha-Tocopherol in marine lipid-based liposomes: In vitro and in vivo studies. Lipids 36:1313-1320
59. Regnault C, Soursac M, Roch-Arveiller M, Postaire E, Hazebroucq G (1996) Pharmacokinetics of superoxide dismutase in rats after oral administration. Biopharm Drug Dispos 17:165-174
60. Regnault C, Roch-Arveiller M, Tissot M, Sarfati G, Giroud JP, Postaire E, Hazebroucq G (1995) Effect of encapsulation on the antiinfl ammatory properties of superoxide dismutase after oral administration. Clin Chim Acta 240:117-127
61. Souto EB, Muller RH (2010) Lipid nanoparticles: Effect on bioavailability and pharmacokinetic changes. Handb Exp Pharmacol 197: 115-141
62. Severino P, Pinho SC, Souto EB, Santana MH (2011) Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles. Colloids Surf B Biointerfaces 86:125-130
63. Hollman PC, Katan MB (1999) Dietary fl avonoids: Intake, health effects and bioavailability. Food Chem Toxicol 37:937-942
64. Wang D, Zhao P, Cuia F, Li X (2007) Preparation and characterization of solid lipid nanoparticles loaded with total fl avones of Hippophae rhamnoides (TFH). PDA J Pharm Sci Technol 61:110-120
65. Nagamoto T, Hattori Y, Takayama K, Maitani Y (2004) Novel chitosan particles and chitosancoated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res 21:671-674
66. Da Silva CF, Severino P, Martins F, Chaud MV, Santana MH (2009) The intestinal permeation of didanosine from granules containing microspheres using the everted gut sac model. J Microencapsul 26:523-528
67. Constantinides PP (1995) Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects. Pharm Res 12:1561-1572
68. Ljusberg-Wahren H, Seier Nielsen F, Brogard M, Troedsson E, Mullertz A (2005) Enzymatic characterization of lipid-based drug delivery systems. Int J Pharm 298:328-332
69. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee YI, Kim DD, Jee JP, Lee YB, Woo JS, Yong CS, Choi HG (2009) Enhanced oral bioavailability of coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm 374:66-72
70. Celardo I, Pedersen JZ, Traversa E, Ghibelli L (2011) Pharmacological potential of cerium oxide nanoparticles. Nanoscale 3:1411-1420
71. Zhou X, Wong LL, Karakoti AS, Seal S, McGinnis JF (2011) Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse. PLoS One 6:e16733